The mucous neck cell in the human gastric corpus: a distinctive, functional cell lineage
- 1 February 1999
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 187 (3) , 331-337
Abstract
There is considerable debate about whether the mucous neck cell (MNC) in the mucosa of the gastric corpus is merely a transit cell population, intermediate between gastric stem cells and the differentiated zymogenic (chief or peptic) cell lineages, or has distinct functions of its own. To cast light on these possibilities, the secretory phenotype of the MNC has been examined. Archival gastric body samples from non-ulcer dyspepsia biopsies and gastrectomies performed for peptic ulcer disease were stained with antibodies to the trefoil peptides TFF1/pS2 and TFF2/SP, pancreatic secretory trypsin inhibitor (PSTI), epidermal growth factor (EGF) and its receptor (EGFR), and to the MUC1 gene product—HMFG2. Human MNCs express PSTI, TFF1/pS2, TFF2/SP, and EGF proteins, while rat MNCs express TFF2/SP; the mucin contained in the MNCs is diastase/periodic acid Schiff (D/PAS)-positive and stains with human milk fat globulin (HMFG2). The canaliculi but not the cytoplasm of adjacent parietal cells were also decorated focally by D/PAS, by HMFG2, and by antibodies to TFF2/SP and TFF1/pS2. These findings favour the hypothesis that MNCs have a defined phenotype and are thus a separate and distinct cell lineage, secreting a number of luminally-active peptides which protect the gastric mucosa, and in particular the adjacent parietal cells, from the effects of secreted gastric acid. Moreover, a considerable degree of similarity in secretory profile is noted between MNCs and the so-called ‘reparative lineages’ in the gut—the ulcer-associated cell lineage (UACL) and hyperplastic polyp epithelium. If, on the other hand, the MNCs are indeed a transit population differentiating into zymogenic or peptic cells, then it is clear that having differentiated into one secretory phenotype producing a range of peptides, the MNC then proceeds to differentiate into a cell with a totally different secretory phenotype, a phenomenon unique in gastrointestinal cell lineage relationships. Copyright © 1999 John Wiley & Sons, Ltd.Keywords
This publication has 32 references indexed in Scilit:
- Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming growth factor alpha mRNAs in rat stomachThe Journal of Pathology, 1995
- Regulation of terminal differentiation of zymogenic cells by transforming growth factor α in transgenic miceGastroenterology, 1995
- Acid suppression and gastric mucosal cell biologyDigestive Diseases and Sciences, 1994
- The ulceration‐associated cell lineage (UACL) reiterates the Brunner's gland differentiation programme but acquires the proliferative organization of the gastric glandThe Journal of Pathology, 1994
- Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway.Journal of Clinical Investigation, 1994
- The expression of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in ‘gastric metaplasia’ of the proximal duodenum: Implications for the nature of ‘gastric metaplasia’The Journal of Pathology, 1993
- Gastric output of pancreatic secretory trypsin inhibitor is increased by misoprostol.Gut, 1991
- Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissuesThe Journal of Pathology, 1990
- Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cellsNature, 1990
- Isolation of a Crystalline Trypsin Inhibitor-Anticoagulant Protein from Pancreas1aJournal of the American Chemical Society, 1948